![](/img/cover-not-exists.png)
Rationale and study design of a randomized controlled trial to assess the effects of maintaining hemoglobin levels using darbepoetin alfa on prevention of development of end-stage kidney disease in non-diabetic CKD patients (PREDICT Trial)
Imai, Enyu, Maruyama, Shoichi, Nangaku, Masaomi, Hirakata, Hideki, Hayashi, Terumasa, Narita, Ichiei, Kono, Hideki, Nakatani, Eiji, Morita, Satoshi, Tsubakihara, Yoshiharu, Akizawa, TadaoVolume:
20
Language:
english
Journal:
Clinical and Experimental Nephrology
DOI:
10.1007/s10157-015-1133-z
Date:
February, 2016
File:
PDF, 380 KB
english, 2016